Skilled Nursing Facility- Long Term Care Open Door Forum Update
|
Home » Archives for 02/08/13
February 08, 2013 SNap(R) Group
|
February 08, 2013 SNap(R) Group
02/07/2013 04:01 PM EST
Patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the drug bevacizumab (Avastin) lived 3.7 months longer than patients who did not receive the drug, according to an interim analysis of a large, randomized clinical trial.
February 08, 2013 SNap(R) Group
|
February 08, 2013 SNap(R) Group
NIH competition awards prizes for audacious ideas in vision research
02/08/2013 11:31 AM EST
Ten winning submissions from a pool of nearly 500 entries have been selected by the National Eye Institute (NEI), part of the National Institutes of Health, for its Audacious Goals challenge, a nationwide competition for compelling, one-page ideas to advance vision science. Each winner will receive a $3,000 prize plus travel expenses to attend the NEI Audacious Goals Development Meeting, Feb. 24-26, 2013, at the Bolger Conference Center in Potomac, Md., outside Washington, D.C.